Table 3.

Results From Free Cytosolic Calcium Dynamic Assays in PitNET Cells in Response to MF Alone or in Combination With Octreotide

TreatmentNo. SamplesCells Analyzed% PRC% PRM ± SEMTime (s) ± SEM
ACTHomas
 MF1/25812.1%20 ± 1.7751.43 ± 1.95
 Octreotide1/2674.5%23.9 ± 3.62110 ± 0
 MF + Octreotide1/2664.5%28.9 ± 5.4445 ± 4.08
GHomas
 MF0/2700
 Octreotide2/27010%21.6 ± 0.889.4 ± 3.71
 MF + Octreotide1/26827.9%37.6 ± 3.8985 ± 0
TreatmentNo. SamplesCells Analyzed% PRC% PRM ± SEMTime (s) ± SEM
ACTHomas
 MF1/25812.1%20 ± 1.7751.43 ± 1.95
 Octreotide1/2674.5%23.9 ± 3.62110 ± 0
 MF + Octreotide1/2664.5%28.9 ± 5.4445 ± 4.08
GHomas
 MF0/2700
 Octreotide2/27010%21.6 ± 0.889.4 ± 3.71
 MF + Octreotide1/26827.9%37.6 ± 3.8985 ± 0

No. samples is the number of responsive samples of the total of samples analyzed. Cells analyzed indicates the total number of individual cells analyzed. % PRC is the percentage of responsive cells in responsive samples. Time is the time of response to biguanide administration.

Table 3.

Results From Free Cytosolic Calcium Dynamic Assays in PitNET Cells in Response to MF Alone or in Combination With Octreotide

TreatmentNo. SamplesCells Analyzed% PRC% PRM ± SEMTime (s) ± SEM
ACTHomas
 MF1/25812.1%20 ± 1.7751.43 ± 1.95
 Octreotide1/2674.5%23.9 ± 3.62110 ± 0
 MF + Octreotide1/2664.5%28.9 ± 5.4445 ± 4.08
GHomas
 MF0/2700
 Octreotide2/27010%21.6 ± 0.889.4 ± 3.71
 MF + Octreotide1/26827.9%37.6 ± 3.8985 ± 0
TreatmentNo. SamplesCells Analyzed% PRC% PRM ± SEMTime (s) ± SEM
ACTHomas
 MF1/25812.1%20 ± 1.7751.43 ± 1.95
 Octreotide1/2674.5%23.9 ± 3.62110 ± 0
 MF + Octreotide1/2664.5%28.9 ± 5.4445 ± 4.08
GHomas
 MF0/2700
 Octreotide2/27010%21.6 ± 0.889.4 ± 3.71
 MF + Octreotide1/26827.9%37.6 ± 3.8985 ± 0

No. samples is the number of responsive samples of the total of samples analyzed. Cells analyzed indicates the total number of individual cells analyzed. % PRC is the percentage of responsive cells in responsive samples. Time is the time of response to biguanide administration.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close